1,936 results found
    1. Human Biology and Medicine

    Research: Adequate statistical power in clinical trials is associated with the combination of a male first author and a female last author

    Willem M Otte et al.
    An analysis of 31,873 clinical trials shows that adequate statistical power was most often present in trials with a male first author and a female last author.
    1. Cancer Biology

    CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials

    Ann Lin et al.
    A putative therapeutic target undergoing clinical trials in breast cancer is non-essential and the drug used in those trials blocks cell division through an off-target effect.
  1. eLife Latest: Supporting AllTrials to encourage the registration and reporting of all clinical trials

    AllTrials is calling for broad scrutiny to help uncover missing results from past clinical trials.
  2. Meta-Research: A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals

    Diana Herrera-Perez et al.
    An analysis of more than 3000 randomized controlled trials published in JAMA, the Lancet and NEJM has identified 396 medical reversals.
    1. Epidemiology and Global Health

    Aging and Geroscience: Putting epigenetic biomarkers to the test for clinical trials

    Jamie N Justice, Stephen B Kritchevsky
    Reliable biomarkers are needed to test the effectiveness of interventions intended to improve health and extend lifespan.
    Insight
    Available as:
    • HTML
    • PDF
    1. Microbiology and Infectious Disease

    Tuberculous Meningitis: Can aspirin help?

    Ashwini Kalantri, Shriprakash Kalantri
    Using a combination of aspirin, anti-tuberculosis drugs and steroids may help to reduce the number of strokes and deaths in patients with tuberculous meningitis.
    Insight
    Available as:
    • HTML
    • PDF
    1. Human biology and medicine

    Point of View: Why clinical translation cannot succeed without failure

    Alex John London, Jonathan Kimmelman
    The high rates of attrition that occur in drug development are widely regarded as problematic, but the failure of well-designed studies benefits both researchers and healthcare systems.
    1. Human Biology and Medicine

    Book Review: Bad medicine

    Richard Smith
    In his new book Ben Goldacre argues that the pharmaceutical industry is in poor health and in urgent need of treatment.
    1. Human Biology and Medicine

    Stem Cells: Put to the test

    Marites T Woon, Timothy J Kamp
    Personalized heart muscle cells made from stem cells in the laboratory could be used to check an individual’s response to potential new drugs before clinical trials.
    Insight
    Available as:
    • HTML
    • PDF
    1. Microbiology and Infectious Disease

    A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults

    Nguyen TH Mai et al.
    Adjunctive aspirin may reduce new brain infarcts and deaths in the first 60 days of treatment for HIV-uninfected adults with tuberculous meningitis.

Refine your results by:

Type
Research categories